Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.

For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.

Earnings